Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 59/100

Termination Rate

10.5%

2 terminated out of 19 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

5%

1 trials in Phase 3/4

Results Transparency

50%

4 of 8 completed with results

Key Signals

4 with results80% success

Data Visualizations

Phase Distribution

7Total
Not Applicable (1)
P 1 (2)
P 2 (3)
P 4 (1)

Trial Status

Completed8
Unknown5
Recruiting4
Terminated2

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (19)

Showing 19 of 19 trials
NCT06730321Recruiting

Surgical Competency for Robot-Assisted Thyroidectomy: Construction and Validation of a Robotic Thyroidectomy Assessment Score (RTAS)

NCT05768178Phase 2Recruiting

DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.

NCT04985604Phase 2Terminated

Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors

NCT04462471Phase 1Completed

Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers

NCT06439745Completed

More Than 50% of Unifocal cN0 T1b/Small T2 Papillary Thyroid Carcinoma May Require Completion Thyroidectomy if Nodal Status is Evaluated

NCT07066644CompletedPrimary

Intraoperative Pathologic Evaluation of Central Lymph Nodes in Papillary Thyroid Carcinoma

NCT03037385Phase 1Completed

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

NCT06254859Recruiting

Intraoperative Neuromuscular Monitoring and Its Impact on Pre- and Postoperative Acoustic Outcomes in Thyroid Surgery

NCT06725576RecruitingPrimary

Ultrasound-Guided Microwave Ablation Vs. Surgery for Low-Risk PapilaryThyroid Carcinoma

NCT06068101CompletedPrimary

Clinical and Genetic Investigation of the Association Between Primary Aldosteronism and Thyroid Cancer

NCT01659385CompletedPrimary

Leptin Levels in Papillary Thyroid Cancer

NCT04644315Phase 2Terminated

A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors

NCT05796960Unknown

European Multicenter Study on Surgical Management of Advanced Thyroid Cancer

NCT02418390Not ApplicableCompletedPrimary

The Efficacy and Safety of Prophylactic Central Lymph Node Dissection in Papillary Thyroid Carcinoma

NCT05247476Phase 4UnknownPrimary

Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused by Thyroidectomy in Thyroid Cancer Patients.

NCT04594720Completed

Circulating Biomarkers to Identify Thyroid Cancer

NCT04411290Unknown

Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases

NCT04396912Unknown

Post-thyroidectomy Vocal Cord Paralysis Along With Hypocalcemia: STROBE - Guided Prospective Cohort

NCT02952612UnknownPrimary

Active Surveillance of Papillary Thyroid Microcarcinoma

Showing all 19 trials

Research Network

Activity Timeline